+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Synthetic Hemostatic Wound Healing Product Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6081588
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The synthetic hemostatic wound healing sector has emerged as a critical component of modern surgical and trauma care, offering rapid solutions to control bleeding and support tissue regeneration. Advanced formulations have evolved from basic powder-based agents to sophisticated nanotechnology-driven adhesives that actively promote hemostasis and healing. This landscape transformation reflects a convergence of material science innovations and clinical demands for faster, safer interventions. Clinicians now rely on a spectrum of products that seamlessly integrate into diverse surgical workflows, from cardiovascular procedures to emergency trauma response.

As the global population ages and healthcare systems intensify focus on cost-effective, quality outcomes, the market for synthetic hemostatic products continues to expand. Regulatory agencies have streamlined approval pathways for next-generation materials, accelerating the adoption of novel adhesives, sealants, and absorbable matrices. Concurrently, technological breakthroughs in biodegradable polymers and 3D-printed architectures have unlocked new possibilities for customizable wound care solutions. By understanding these multidimensional forces-clinical pressures, regulatory shifts, and material science breakthroughs-stakeholders can position themselves at the forefront of this dynamic market.

Transformative Shifts Redefining Hemostatic Wound Care

Over the past decade, the hemostatic wound care landscape has undergone transformative shifts driven by emerging clinical needs and technological breakthroughs. Minimally invasive surgeries have surged, prompting demand for adhesives that deliver rapid adhesion to tissue while minimizing surgical trauma. Simultaneously, military and disaster response scenarios have spurred the development of portable, anhydrous sealants designed for field use under austere conditions. Biodegradable polymers and nanoparticle adhesives have transitioned from research labs to commercial offerings, enabling targeted, controlled release profiles that accelerate clot formation and tissue repair.

Moreover, digital health integration-through smart dressings embedded with sensors-has redefined postoperative monitoring, allowing clinicians to track healing progress in real time. Industry partnerships between medical device firms and materials science researchers have fostered hybrid solutions that blend natural and synthetic components, such as collagen-based hydrogels reinforced with polyethylene glycol networks. These alliances have unlocked synergies that address both hemostatic efficacy and ease of application. Consequently, the sector is evolving from single-product focus to comprehensive wound management platforms, setting new benchmarks for safety, efficacy, and patient satisfaction.

Assessing the Cumulative Impact of 2025 U.S. Tariffs

In 2025, significant U.S. tariffs on imported medical materials have reshaped supply chains and cost structures within the hemostatic product market. Raw materials sourced from international suppliers now face up to 15 percent duties, elevating input costs for foam, gel, powder, and sponge formats. Domestic manufacturers have responded by reshoring production of key components such as polysaccharide-based polymers and polyvinyl alcohol derivatives, mitigating tariff burdens but incurring capital investment in new facilities.

Consequently, pricing strategies have shifted, with end users experiencing modest increases in product costs, particularly for advanced adhesive sealant systems and hemostatic agents reliant on hydrogel-based or chitosan-based inputs. To preserve margins, companies have accelerated adoption of synthetic blend sources and biodegradable polymers that bypass tariff classifications. In parallel, strategic partnerships with U.S. distributors have optimized logistics, reducing lead times and import-related complexities. Overall, the tariff environment has catalyzed a recalibration of global sourcing strategies, driving innovation in local manufacturing and supply chain resilience.

Key Segmentation Insights Driving Market Dynamics

A nuanced understanding of market segmentation reveals critical drivers underpinning product adoption and R&D focus. By type, Natural Hemostats such as cellulose-based, collagen-based, fibrin-based, and gelatin-based matrices continue to compete with Synthetic Hemostats including hydrogel-based, polyethylene glycol, polysaccharide-based, and polyvinyl alcohol formulations. Sourcing strategies range from animal-derived and plant-derived options like alginate, Aloe Vera, and chitosan, to synthetic blends engineered for consistent performance.

In clinical settings, applications span surgical wounds in cardiovascular, general, neurological, obstetrics and gynecology, and orthopedic procedures, as well as trauma cases involving accidental injuries, disaster response, and military wounds. End users encompass ambulatory surgery centers in anesthetic and orthopedic specialties, family and specialty clinics, consumer care through first aid kits and home care, and both private and public hospitals. Technical differentiation emerges from mechanisms of action-absorbent, anhydrous sealant, rapid adhesion to tissue, swelling and gelation-delivered in foam, gel, powder, and sponge forms. Products bifurcate into adhesive sealant systems and hemostatic agents, while cutting-edge solutions feature 3D printed flakes, biodegradable polymers, and nanoparticle adhesives. Age-specific considerations address adult, geriatric, and pediatric populations, and development pipelines navigate clinical trial phases from preclinical to Phase IV.

Key Regional Insights Shaping Global Growth Patterns

Regional dynamics profoundly influence strategic priorities and deployment of hemostatic wound care solutions. In the Americas, robust healthcare infrastructure and streamlined regulatory processes facilitate rapid adoption of next-generation adhesives and sealants, particularly in high-volume surgical centers. North American manufacturers benefit from onshore production capabilities that align with evolving tariff landscapes, maintaining supply chain agility.

Europe, the Middle East & Africa present a heterogeneous picture: Western European markets exhibit strong reimbursement frameworks for advanced wound care, while emerging economies in Eastern Europe, the Gulf region, and Africa prioritize cost-effective, plant-derived hemostats to address growing trauma care needs. Collaborative efforts between local distributors and global companies have expanded access in remote locations.

Asia-Pacific is characterized by rapid expansion in surgical volumes, driven by aging populations in Japan and China and rising healthcare investments in Southeast Asia. Regulatory regimes vary, prompting multinational firms to localize sourcing of biodegradable polymers and nanoparticle adhesives. Strategic alliances with regional manufacturers ensure regulatory compliance and market penetration, fostering sustained growth across diverse healthcare landscapes.

Key Company Insights Fueling Innovation and Competition

Competitive dynamics hinge on continuous innovation and strategic partnerships among leading industry players. Advanced Medical Solutions Group plc champions proprietary polymer networks that enhance clot stability, while Arch Therapeutics, Inc. leverages self-assembling peptides for rapid tissue adhesion. B. Braun Medical Inc. has reinforced its portfolio with cellulose-based matrices optimized for surgical hemostasis, and Baxter International Inc. expands collagen scaffold offerings to improve biocompatibility.

Biolife, LLC and CR Bard, Inc. pursue novel fibrin and hydrogel adhesives respectively, and CSL Behring LLC advances rapid adhesion materials tailored for cardiovascular applications. Entegrion, Inc. delivers anhydrous sealants suitable for austere environments, while HemCon Medical Technologies, Inc. drives chitosan-based innovations. Johnson & Johnson integrates proprietary polyethylene glycol blends across multiple product lines, and Medtronic plc focuses on synthetic blend formulations certified for orthopedic use. Pfizer Inc. explores nanoparticle adhesives in preclinical trials, Sanofi invests in biodegradable polymers, Stryker Corporation improves foam and gel delivery systems, and Z-Medica, LLC pioneers next-generation rapid hemostasis agents for trauma care.

Actionable Recommendations for Industry Leaders

To capitalize on evolving market dynamics, industry leaders should prioritize targeted investments in material science research, particularly in biodegradable polymers and nanoparticle adhesives that address unmet clinical needs. Establishing cross-functional partnerships between R&D, regulatory affairs, and supply chain teams will streamline development pipelines and ensure compliance with diverse regional regulations. Leaders must also pursue strategic alliances with manufacturing partners to localize production, mitigating tariff exposures and reducing time to market.

Expanding clinical evidence through multi-phase trials across surgical and trauma settings will strengthen product differentiation and support premium pricing strategies. Furthermore, integrating digital health capabilities-such as sensor-enabled dressings-can drive post-market surveillance and real-world evidence generation. To enhance market access, companies should develop tailored commercial models for ambulatory surgery centers, clinics, consumer care, and hospital networks. Engaging payers and health technology assessment bodies early will facilitate favorable reimbursement pathways. By adopting these recommendations, leaders can unlock new growth avenues, optimize operational efficiencies, and reinforce competitive positioning.

Conclusion: Synthesizing Market Trends and Opportunities

The synthetic hemostatic wound healing market stands at a pivotal juncture, guided by converging technological, regulatory, and clinical forces. Emerging materials such as biodegradable polymers and nanoparticle adhesives have redefined performance expectations, while global supply chain realignments prompted by tariff policies have underscored the importance of resilient manufacturing networks. Regional disparities in regulatory frameworks and healthcare infrastructure present both challenges and opportunities, compelling companies to adopt localized strategies without sacrificing global scale.

Competitive pressure from industry leaders and agile disruptors alike has intensified, driving a cycle of continuous innovation and evidence-based differentiation. Successful players will be those who integrate comprehensive segmentation insights-from type and source through application and end user-into cohesive product portfolios. By aligning R&D, commercial, and regulatory efforts, organizations can address diverse clinical demands, secure favorable reimbursement, and maintain a sustainable growth trajectory. The road ahead demands agility, collaboration, and unwavering commitment to advancing patient outcomes.

Market Segmentation & Coverage

This research report categorizes the Synthetic Hemostatic Wound Healing Product Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Natural Hemostats
    • Cellulose-Based
    • Collagen-Based
    • Fibrin-Based
    • Gelatin-Based
  • Synthetic Hemostats
    • Hydrogel-Based
    • Polyethylene Glycol
    • Polysaccharide-Based
    • Polyvinyl Alcohol
  • Animal-Derived
  • Plant-Derived
    • Alginate
    • Aloe Vera
    • Chitosan
  • Synthetic Blend
  • Surgical Wounds
    • Cardiovascular Surgery
    • General Surgery
    • Neurological Surgery
    • Obstetrics and Gynecology
    • Orthopedic Surgery
  • Trauma Cases
    • Accidental Injuries
    • Disaster Response Scenarios
    • Military Wounds
  • ASCs
    • Anesthetic ASCs
    • Orthopedic ASCs
  • Clinics
    • Family Clinics
    • Specialty Clinics
  • Consumer Care
    • First Aid Kits
    • Home Care
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Absorbent
  • Anhydrous Sealant
  • Rapid Adhesion to Tissue
  • Swelling and Gelation
  • Foam
  • Gel
  • Powder
  • Sponge
  • Adhesive Sealant Systems
  • Hemostatic Agents
  • 3D Printed Flakes
  • Biodegradable Polymers
  • Nanoparticle Adhesives
  • Adult
  • Geriatric
  • Pediatric
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Preclinical Trials

This research report categorizes the Synthetic Hemostatic Wound Healing Product Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Synthetic Hemostatic Wound Healing Product Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Advanced Medical Solutions Group plc
  • Arch Therapeutics, Inc.
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Biolife, LLC
  • CR Bard, Inc.
  • CSL Behring LLC
  • Entegrion, Inc.
  • HemCon Medical Technologies, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Pfizer Inc.
  • Sanofi
  • Stryker Corporation
  • Z-Medica, LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Synthetic Hemostatic Wound Healing Product Market, by Type
8.1. Introduction
8.2. Natural Hemostats
8.2.1. Cellulose-Based
8.2.2. Collagen-Based
8.2.3. Fibrin-Based
8.2.4. Gelatin-Based
8.3. Synthetic Hemostats
8.3.1. Hydrogel-Based
8.3.2. Polyethylene Glycol
8.3.3. Polysaccharide-Based
8.3.4. Polyvinyl Alcohol
9. Synthetic Hemostatic Wound Healing Product Market, by Source
9.1. Introduction
9.2. Animal-Derived
9.3. Plant-Derived
9.3.1. Alginate
9.3.2. Aloe Vera
9.3.3. Chitosan
9.4. Synthetic Blend
10. Synthetic Hemostatic Wound Healing Product Market, by Application
10.1. Introduction
10.2. Surgical Wounds
10.2.1. Cardiovascular Surgery
10.2.2. General Surgery
10.2.3. Neurological Surgery
10.2.4. Obstetrics and Gynecology
10.2.5. Orthopedic Surgery
10.3. Trauma Cases
10.3.1. Accidental Injuries
10.3.2. Disaster Response Scenarios
10.3.3. Military Wounds
11. Synthetic Hemostatic Wound Healing Product Market, by End User
11.1. Introduction
11.2. ASCs
11.2.1. Anesthetic ASCs
11.2.2. Orthopedic ASCs
11.3. Clinics
11.3.1. Family Clinics
11.3.2. Specialty Clinics
11.4. Consumer Care
11.4.1. First Aid Kits
11.4.2. Home Care
11.5. Hospitals
11.5.1. Private Hospitals
11.5.2. Public Hospitals
12. Synthetic Hemostatic Wound Healing Product Market, by Mechanism of Action
12.1. Introduction
12.2. Absorbent
12.3. Anhydrous Sealant
12.4. Rapid Adhesion to Tissue
12.5. Swelling and Gelation
13. Synthetic Hemostatic Wound Healing Product Market, by Material Form
13.1. Introduction
13.2. Foam
13.3. Gel
13.4. Powder
13.5. Sponge
14. Synthetic Hemostatic Wound Healing Product Market, by Product
14.1. Introduction
14.2. Adhesive Sealant Systems
14.3. Hemostatic Agents
15. Synthetic Hemostatic Wound Healing Product Market, by Technological Development
15.1. Introduction
15.2. 3D Printed Flakes
15.3. Biodegradable Polymers
15.4. Nanoparticle Adhesives
16. Synthetic Hemostatic Wound Healing Product Market, by Age Group
16.1. Introduction
16.2. Adult
16.3. Geriatric
16.4. Pediatric
17. Synthetic Hemostatic Wound Healing Product Market, by Clinical Trial Phase
17.1. Introduction
17.2. Phase I
17.3. Phase II
17.4. Phase III
17.5. Phase IV
17.6. Preclinical Trials
18. Americas Synthetic Hemostatic Wound Healing Product Market
18.1. Introduction
18.2. Argentina
18.3. Brazil
18.4. Canada
18.5. Mexico
18.6. United States
19. Asia-Pacific Synthetic Hemostatic Wound Healing Product Market
19.1. Introduction
19.2. Australia
19.3. China
19.4. India
19.5. Indonesia
19.6. Japan
19.7. Malaysia
19.8. Philippines
19.9. Singapore
19.10. South Korea
19.11. Taiwan
19.12. Thailand
19.13. Vietnam
20. Europe, Middle East & Africa Synthetic Hemostatic Wound Healing Product Market
20.1. Introduction
20.2. Denmark
20.3. Egypt
20.4. Finland
20.5. France
20.6. Germany
20.7. Israel
20.8. Italy
20.9. Netherlands
20.10. Nigeria
20.11. Norway
20.12. Poland
20.13. Qatar
20.14. Russia
20.15. Saudi Arabia
20.16. South Africa
20.17. Spain
20.18. Sweden
20.19. Switzerland
20.20. Turkey
20.21. United Arab Emirates
20.22. United Kingdom
21. Competitive Landscape
21.1. Market Share Analysis, 2024
21.2. FPNV Positioning Matrix, 2024
21.3. Competitive Analysis
21.3.1. Advanced Medical Solutions Group plc
21.3.2. Arch Therapeutics, Inc.
21.3.3. B. Braun Medical Inc.
21.3.4. Baxter International Inc.
21.3.5. Biolife, LLC
21.3.6. CR Bard, Inc.
21.3.7. CSL Behring LLC
21.3.8. Entegrion, Inc.
21.3.9. HemCon Medical Technologies, Inc.
21.3.10. Johnson & Johnson
21.3.11. Medtronic plc
21.3.12. Pfizer Inc.
21.3.13. Sanofi
21.3.14. Stryker Corporation
21.3.15. Z-Medica, LLC
22. ResearchAI
23. ResearchStatistics
24. ResearchContacts
25. ResearchArticles
26. Appendix
List of Figures
FIGURE 1. SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET MULTI-CURRENCY
FIGURE 2. SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET MULTI-LANGUAGE
FIGURE 3. SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 20. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2024 VS 2030 (%)
FIGURE 22. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 24. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2024 VS 2030 (%)
FIGURE 26. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 30. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 32. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 33. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 35. SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 36. SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CELLULOSE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY FIBRIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY GELATIN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HYDROGEL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY POLYSACCHARIDE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY POLYVINYL ALCOHOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ANIMAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ALOE VERA, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC BLEND, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY OBSTETRICS AND GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ACCIDENTAL INJURIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY DISASTER RESPONSE SCENARIOS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MILITARY WOUNDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ANESTHETIC ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ORTHOPEDIC ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY FAMILY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY FIRST AID KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ABSORBENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ANHYDROUS SEALANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY RAPID ADHESION TO TISSUE, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SWELLING AND GELATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY FOAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SPONGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ADHESIVE SEALANT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY 3D PRINTED FLAKES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NANOPARTICLE ADHESIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRECLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 142. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 144. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 145. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 147. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 149. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 150. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 152. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 153. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 154. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 155. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 156. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 157. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 159. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 160. CANADA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 161. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 166. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 169. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 172. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 173. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 175. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 176. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 177. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 179. MEXICO SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 187. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 188. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 190. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 192. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 193. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 194. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 195. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 212. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 214. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 217. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 218. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 225. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 237. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. AUSTRALIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 239. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 241. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 242. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 243. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 244. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 245. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 246. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 247. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 249. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 250. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 251. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 253. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 254. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 256. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 257. CHINA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 258. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY NATURAL HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 260. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SYNTHETIC HEMOSTATS, 2018-2030 (USD MILLION)
TABLE 261. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 262. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PLANT-DERIVED, 2018-2030 (USD MILLION)
TABLE 263. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY SURGICAL WOUNDS, 2018-2030 (USD MILLION)
TABLE 265. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TRAUMA CASES, 2018-2030 (USD MILLION)
TABLE 266. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY ASCS, 2018-2030 (USD MILLION)
TABLE 268. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CONSUMER CARE, 2018-2030 (USD MILLION)
TABLE 270. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 271. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MECHANISM OF ACTION, 2018-2030 (USD MILLION)
TABLE 272. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY MATERIAL FORM, 2018-2030 (USD MILLION)
TABLE 273. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 274. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TECHNOLOGICAL DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 275. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 276. INDIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY CLINICAL TRIAL PHASE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA SYNTHETIC HEMOSTATIC WOUND HEALING PRODUCT MARKET SIZE, BY TYPE,

Companies Mentioned

  • Advanced Medical Solutions Group plc
  • Arch Therapeutics, Inc.
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Biolife, LLC
  • CR Bard, Inc.
  • CSL Behring LLC
  • Entegrion, Inc.
  • HemCon Medical Technologies, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Pfizer Inc.
  • Sanofi
  • Stryker Corporation
  • Z-Medica, LLC

Methodology

Loading
LOADING...